Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab improves the quality of response in patients with previously untreated chronic lymphocytic leukemia.

被引：0

作者：

Weiss, MA ^{[1
]}

Lamanna, N ^{[1
]}

Gencarelli, A ^{[1
]}

Scheinberg, DA ^{[1
]}

Maslak, PG ^{[1
]}

Horgan, D ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10021 USA

来源：

BLOOD | 2002年 / 100卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5019

引用

页码：365B / 365B

页数：1

共 50 条

[31] Preliminary results of the combination rituximab, fludarabine, cyclophosphamide and mitoxantrone (R-FCM) followed by rituximab maintenance in previously untreated chronic lymphocytic leukemia
Bosch, Francesc
Muntanola, Ana
Villamor, Neus
Terol, Maria Jose
Gonzalez-Barca, Elena
Ribera, Josep Maria
Gonzalez, Marcos
Abella, Eugenia
Delgado, Julio
Carbonell, Felix
Garcia-Marco, Jose A.
Escoda, Lourdes
Ferrer, Secundino
Monzo, E.
Gonzalez, Yolanda
Abrisqueta, Pau
Salamero, Olga
Gine, Eva
Montserrat, Emili
BLOOD, 2007, 110 (11) : 193A - 193A
[32] Pentostatin, cyclophosphamide, and rituximab show significant clinical activity in patients with previously untreated chronic lymphocytic leukemia
Nicole Lamanna
Mark A. Weiss
Current Oncology Reports, 2007, 9 (5) : 335 - 336
[33] Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia
Badoux, Xavier C.
Keating, Michael J.
Wang, Xuemei
O'Brien, Susan M.
Ferrajoli, Alessandra
Faderl, Stefan
Burger, Jan
Koller, Charles
Lerner, Susan
Kantarjian, Hagop
Wierda, William G.
BLOOD, 2011, 118 (08) : 2085 - 2093
[34] Phase II multicenter trial of pentostatin and rituximab in patients with previously treated or untreated chronic lymphocytic leukemia.
Drapkin, R
Di Bella, NJ
Cuasay, LC
Edelman, G
Richards, D
Mirabel, M
Asmar, L
BLOOD, 2002, 100 (11) : 803A - 803A
[35] Fludarabine, Cyclophosphamide, Rituximab (FCR) and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL) - Final Results of a Phase I/II Study
Shadman, Mazyar
Gopal, Ajay K.
Press, Oliver
Maloney, David G.
Mawad, Raya
Wadsworth, Troy
Dennie, Trevor W.
Schultheiss, Karl
Kojouri, Kiarash
Kammerer, Britt E.
Pagel, John M.
BLOOD, 2016, 128 (22)
[36] Combined fludarabine, cyclophosphamide, and rituximab achieves a high complete remission rate as initial treatment for chronic lymphocytic leukemia.
Wierda, W
O'Brien, S
Albitar, M
Lerner, S
Plunkett, W
Giles, F
Andreeff, M
Cortes, J
Faderl, S
Thomas, D
Koller, C
Kantarjian, H
Keating, M
BLOOD, 2001, 98 (11) : 771A - 771A
[37] CHEMOIMMUNOTHERAPY WITH OFATUMUMAB, FLUDARABINE AND CYCLOPHOSPHAMIDE IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A PHASE II INTERNATIONAL TRIAL
Wierda, G.
Kipps, T.
Duerig, J.
Griskevicius, L.
Stilgenbauer, S.
Mayer, J.
Smolej, L.
Hess, G.
Griniute, R.
Hernandez-Ilizaliturri, F.
Padmanabhan, S.
Gorczyca, M.
Gupta, I.
Nielsen, T.
Russell, C.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 320 - 321
[38] Leustatin(R) in the treatment of patients with previously untreated chronic lymphocytic leukemia.
Tallman, MS
Wollins, E
Jain, V
Schiller, G
Shepherd, J
Silver, R
Peterson, L
BLOOD, 1997, 90 (10) : 2574 - 2574
[39] Oral fludarabine and cyclophosphamide in previously untreated chronic lymphocytic leukemia (CLL): Preliminary data.
Cazin, B
Binet, JL
Divine, M
Lepretre, S
Lederlin, P
Travade, P
Lemaire, G
Guibon, O
BLOOD, 2000, 96 (11) : 515A - 515A
[40] Fludarabine and cyclophosphamide: A highly active and well tolerated regimen for patients with previously untreated chronic lymphocytic leukemia (CLL).
Flinn, IW
Byrd, JC
Morrison, C
Jamison, J
Miller, C
Christie, RJ
Gore, S
Burke, P
Vogelsang, G
Grever, MR
BLOOD, 1998, 92 (10) : 104A - 104A

← 1 2 3 4 5 →